Brief: Conmed Corporation Announces Q4 And Full-Year 2022 Financial Results

Conmed

02/02/2023 21:55

Feb 2 (Reuters) - Conmed Corp  CNMD.N :
    * ORATION ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022
FINANCIAL
RESULTS
    * QTRLY SALES $250.9 MILLION DECREASED 8.4% YEAR OVER YEAR
AS
REPORTED
    * QTRLY EPS $0.86
    * QTRLY ADJUSTED EARNINGS PER SHARE$0.42
    * EXPECTS FULL-YEAR 2023 REPORTED REVENUE BETWEEN $1.170
BILLION
AND $1.220 BILLION
    * SEES 2023 ADJUSTED NET EARNINGS PER SHARE IN RANGE OF
$3.20 TO
$3.45
    * FY2023 EARNINGS PER SHARE VIEW $3.37, REVENUE VIEW $1.21
BILLION
-- REFINITIV IBES DATA
    * Q4 EARNINGS PER SHARE VIEW $0.90, REVENUE VIEW $302.5
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw1xRDv8a 
Further company coverage:  CNMD.N 
 ((Reuters.Briefs@thomsonreuters.com;))